Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
mediate decrease » mediated defense (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
mediate decrease » mediated defense (Expand Search)
-
181
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
182
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
183
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
184
-
185
-
186
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
HFD decreases intermediate-term memory.
Published 2025“…(C) Food intake was not significantly different between ND- and HFD-fed flies during the 1 hour. …”
-
198
-
199
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
-
200
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”